Abstract:Objective To analyze clinical characteristics,therapeutic response and outcomes of systemic lupus erythematosus (SLE) complicated with severe thrombocytopenia.Methods Twenty-nine SLE patients with severe thrombocytopenia in Peking University First Hospital from January 2009 to April 2015 were retrospectively analyzed.The patients were divided into good therapeutic response group(platelet count ≥ 80 × 109/L,19 cases) and poor therapeutic response group (platelet count ＜ 80 × 109/L,10 cases) after treament with consequence of glucocorticoid and immunosuppressive agents.Clinical characteristics,laboratory indexes,disease activity[SLE Disease Activity Index(SLEDAI)] and outcomes were recorded.Results Platelet count,hemoglobin level,white blood cell count,anti-dsDNA antibody titer,anti-nRNP antibody positive rate,anti-rRNP antibody positive rate,anti-SSA antibody positive rate,anti-SSB antibody positive rate,anticardiolipin antibody positive rate and C3,C4 levels had no significant differences between groups before treatment (P ＞ 0.05).Platete count in poor therapeutic response group was significantly lower than that in good therapeutic response group after treatment[(27 ± 13) × 109/L vs(148 ±58) × 109/L] (P ＜0.01).The incidence of bleeding had no significant difference between groups (P ＞ 0.05).The SLEDAI score had no significant difference between groups(P ＞ 0.05).There were 3 death(30.0％) caused by severe infection and 3 loss of follow-up(30.0％) in poor therapeutic response group;the mean follow-up time of 4 cases was (10 ± 9) months;the mean platelet count in final follow-up was (145 ± 124) × 109/L,with 2 cases of normal platelet count.There were 5 loss of follow-up(26.3％) in good therapeutic response group;the mean follow-up time of 14 cases was (24 ± 19) months;the mean platelet count in final follow-up was (193 ± 53) × 109/L.Conclusions Severe hemorrhage is not common in SLE complicated with severe thrombocytopenia.Long-term therapeutic effect of glucocorticoid is good.The major cause of death is infection.

Clinical characteristics of systemic lupus erythematosus associated thrombotic thrombocytopenic purpura

Thrombotic Thrombocytopenic Purpura in Patients with Systemic Lupus Erythematosus

Diagnosis and management of acquired thrombotic thrombocytopenic purpura in southeast China: a single center experience of 60 cases

Causes of Death in Hospitalized Patients with Systemic Lupus Erythematosus: a 10-Year Multicenter Nationwide Chinese Cohort

Pd-1(+)Cxcr5(-)Cd4(+)T Cells Are Correlated With The Severity Of Systemic Lupus Erythematosus

A 21-Year-old Woman with Thrombotic Thrombocytopenic Purpura As Initial Symptom of Systemic Lupus Erythematosus and a Literature Review.

Clinical features and prognosis of patients with thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a review of 25 cases

Systemic Lupus Erythematosus and Thrombotic Thrombocytopenic Purpura:Report of Three Cases

Clinicopathological Characteristics And Outcome Of Chinese Patients With Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome: A 9-Year Retrospective Study

Clinical-pathological Features and Prognosis of Thrombotic Thrombocytopenic Purpura in Patients with Lupus Nephritis.

[A Clinical Study of Congenital Thrombotic Thrombocytopenic Purpura].

Clinical-pathological features and prognosis of thrombotic tbrombocytopenic purpura in patients with lupus nephritis

Clinical Analysis of 59 Patients with Thrombotic Thrombocytopenic Purpura

Systemic Lupus Erythematosus (SLE) with Acute Nephritis, Antineutrophil Cytoplasmic Antibody- (ANCA-) Associated Vasculitis, and Thrombotic Thrombocytopenic Purpura (TTP): A Rare Case Report with Literature Review

Effects of Blood Purification in the Treatment of Systemic Lupus Erythematosus Patients with Thrombotic Thrombocytopenia Purpura

Clinical Characteristics of Systemic Lupus Erythematosus Associated with Severe Thrombocytopenia

Comparison of clinical characteristics of first-episode thrombotic thrombocytopenic purpura and TTP-like syndrome: a retrospective cohort study in a level I hematology center in China

Atypical Presentation of Thrombotic Thrombocytopenic Purpura (TTP) as an Initial Manifestation of Systemic Lupus Erythematosus (SLE) in a Young Male

Clinical Spectrum and Prognosis of SLE-associated Severe Thrombopenia: A Single-Center Review of 162 Treatment-Naïve Patients

Lupus Nephritis Combined with Renal Injury Due to Thrombotic Thrombocytopaenic Purpura-Haemolytic Uraemic Syndrome.

Therapeutic response and outcomes of systemic lupus erythematosus complicated with severe thrombocytopenia